UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 549

Sortiert nach

Molecular mechanisms controlling the migration of striatal interneurons

The Journal of neuroscience, 2015-06, Vol.35 (23), p.8718-8729

2015

Link zum Volltext

Verfügbarkeit prüfen

Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study

British journal of cancer, 2011-05, Vol.104 (11), p.1686-1690

2011

Link zum Volltext

Verfügbarkeit prüfen

P.1.e.023 Functional mutations in CADPS identified in patients with early-onset bipolar disorder

European neuropsychopharmacology, 2015-09, Vol.25, p.S222-S223

2015

Link zum Volltext

Verfügbarkeit prüfen

A simple blood test expedites the diagnosis of GLUT1 deficiency syndrome

European journal of paediatric neurology, 2017-06, Vol.21, p.e136-e136

2017

Link zum Volltext

Verfügbarkeit prüfen

Tumor growth rate analysis of progression-free survival (PFS) and overall survival (OS) for patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) receiving placebo or regorafenib in the phase 3 GRID trial

Annals of oncology, 2017-09, Vol.28, p.v534-v535

2017

Link zum Volltext

Verfügbarkeit prüfen

Tumor growth rate analysis of progression-free survival (PFS) and overall survival (OS) for thyroid cancer patients receiving placebo or sorafenib in the phase 3 DECISION trial

Annals of oncology, 2016-10, Vol.27, p.vi331-vi331

2016

Link zum Volltext

Verfügbarkeit prüfen

Analysis of tumor growth rate for advanced hepatocellular cancer patients receiving placebo or sorafenib in the phase 3 SHARP and Asia Pacific trials

Annals of oncology, 2016-10, Vol.27, p.vi237-vi237

2016

Link zum Volltext

Verfügbarkeit prüfen

ARASENS: A phase 3 trial of darolutamide in males with metastatic hormone-sensitive prostate cancer (mHSPC)

Annals of oncology, 2017-09, Vol.28, p.v291-v292

2017

Link zum Volltext

Verfügbarkeit prüfen

Branching and nucleokinesis defects in migrating interneurons derived from doublecortin knockout mice

Human molecular genetics, 2006-05, Vol.15 (9), p.1387-1400

2006

Link zum Volltext

Verfügbarkeit prüfen

Human disorders of cortical development: from past to present

The European journal of neuroscience, 2006-02, Vol.23 (4), p.877-893

2006

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of PIK3 Signaling Pathway Members by the Ovotoxicant 4-Vinylcyclohexene Diepoxide in Rats

Biology of reproduction, 2011-04, Vol.84 (4), p.743-751

2011

Link zum Volltext

Verfügbarkeit prüfen

An updated overall survival analysis with correction for protocol-planned crossover of the international, phase III, randomized, placebo-controlled trial of regorafenib in advanced gastrointestinal stromal tumors after failure of imatinib and sunitinib (GRID)

Annals of oncology, 2015-10, Vol.26, p.vi96

2015

Link zum Volltext

Verfügbarkeit prüfen

Subgroup analysis of patients with metastatic colorectal cancer (mCRC) treated with regorafenib (REG) in the phase 3b CONSIGN trial who had progression-free survival (PFS) >4 months (m)

Annals of oncology, 2016-10, Vol.27, p.vi167-vi167

2016

Link zum Volltext

Verfügbarkeit prüfen

Final overall survival analysis of patients with locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer (RAI-rDTC) treated with sorafenib in the phase 3 DECISION trial: An exploratory crossover adjustment analyses

Annals of oncology, 2016-10, Vol.27, p.vi329-vi329

2016

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety of regorafenib (REG) in advanced gastrointestinal stromal tumors (GIST): updated safety data of the phase 3 GRID trial

Annals of oncology, 2016-10, Vol.27, p.vi489-vi489

2016

Link zum Volltext

Verfügbarkeit prüfen

O-016 Exploratory analysis of tumor growth rate in patients with advanced gastrointestinal stromal tumors (GIST) treated with regorafenib in the GRID phase 3 trial

Annals of oncology, 2015-06, Vol.26, p.iv114

2015

Link zum Volltext

Verfügbarkeit prüfen

PD-012 Analysis of patients ≥75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC)

Annals of oncology, 2016-06, Vol.27, p.ii106

2016

Link zum Volltext

Verfügbarkeit prüfen

PD-012Analysis of patients greater than or equal to 75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC)

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii106-ii106

2016

Link zum Volltext

Verfügbarkeit prüfen

PD-012Analysis of patients ≥75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC)

Annals of oncology, 2016-06, Vol.27 (Suppl 2), p.ii106-ii106

2016

Link zum Volltext

Verfügbarkeit prüfen

Concur: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Regorafenib Monotherapy in Asian Patients with Previously Treated Metastatic Colorectal Cancer (MCRC)

Annals of oncology, 2014-06, Vol.25, p.ii114-ii114

2014

Link zum Volltext

Verfügbarkeit prüfen

Subgroup Analysis of Asian Patients in the Phase III Trial (GRID) of Regorafenib in Pretreated Metastatic GIST

Annals of oncology, 2013-11, Vol.24, p.ix6

2013

Link zum Volltext

Verfügbarkeit prüfen

A phase 3 randomized, double-blind, placebo-controlled trial of ODM-201 vs. placebo in combination with standard androgen deprivation therapy and docetaxel in patients with metastatic hormone-sensitive prostate cancer (ARASENS)

European urology supplements : official journal of the European Association of Urology, 2017-03, Vol.16 (3), p.e356-e357

2017

Link zum Volltext

Verfügbarkeit prüfen

Doublecortin interacts with the ubiquitin protease DFFRX, which associates with microtubules in neuronal processes

Molecular and cellular neuroscience, 2005, Vol.28 (1), p.153-164

2005

Link zum Volltext

Verfügbarkeit prüfen

Equilibrium properties of ternary polymer solutions as explained by the renormalization group

Colloid and polymer science, 1990-11, Vol.268 (11), p.995-1017

1990

Link zum Volltext

Verfügbarkeit prüfen

Branching and nucleokinesis defects in migrating interneurons derived from doublecortin knockout mice

Human molecular genetics, 2006-07, Vol.15 (13), p.2183-2183

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 549

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(449)
Mit Volltextzugriff
(506)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Molecular mechanisms controlling the migration of striatal interneurons

Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study

P.1.e.023 Functional mutations in CADPS identified in patients with early-onset bipolar disorder

A simple blood test expedites the diagnosis of GLUT1 deficiency syndrome

Tumor growth rate analysis of progression-free survival (PFS) and overall survival (OS) for patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) receiving placebo or regorafenib in the phase 3 GRID trial

Tumor growth rate analysis of progression-free survival (PFS) and overall survival (OS) for thyroid cancer patients receiving placebo or sorafenib in the phase 3 DECISION trial

Analysis of tumor growth rate for advanced hepatocellular cancer patients receiving placebo or sorafenib in the phase 3 SHARP and Asia Pacific trials

ARASENS: A phase 3 trial of darolutamide in males with metastatic hormone-sensitive prostate cancer (mHSPC)

Branching and nucleokinesis defects in migrating interneurons derived from doublecortin knockout mice

Human disorders of cortical development: from past to present

Inhibition of PIK3 Signaling Pathway Members by the Ovotoxicant 4-Vinylcyclohexene Diepoxide in Rats

An updated overall survival analysis with correction for protocol-planned crossover of the international, phase III, randomized, placebo-controlled trial of regorafenib in advanced gastrointestinal stromal tumors after failure of imatinib and sunitinib (GRID)

Subgroup analysis of patients with metastatic colorectal cancer (mCRC) treated with regorafenib (REG) in the phase 3b CONSIGN trial who had progression-free survival (PFS) >4 months (m)

Final overall survival analysis of patients with locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer (RAI-rDTC) treated with sorafenib in the phase 3 DECISION trial: An exploratory crossover adjustment analyses

Long-term safety of regorafenib (REG) in advanced gastrointestinal stromal tumors (GIST): updated safety data of the phase 3 GRID trial

O-016 Exploratory analysis of tumor growth rate in patients with advanced gastrointestinal stromal tumors (GIST) treated with regorafenib in the GRID phase 3 trial

PD-012 Analysis of patients ≥75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC)

PD-012Analysis of patients greater than or equal to 75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC)

PD-012Analysis of patients ≥75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC)

Concur: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Regorafenib Monotherapy in Asian Patients with Previously Treated Metastatic Colorectal Cancer (MCRC)

Subgroup Analysis of Asian Patients in the Phase III Trial (GRID) of Regorafenib in Pretreated Metastatic GIST

A phase 3 randomized, double-blind, placebo-controlled trial of ODM-201 vs. placebo in combination with standard androgen deprivation therapy and docetaxel in patients with metastatic hormone-sensitive prostate cancer (ARASENS)

Doublecortin interacts with the ubiquitin protease DFFRX, which associates with microtubules in neuronal processes

Equilibrium properties of ternary polymer solutions as explained by the renormalization group

Branching and nucleokinesis defects in migrating interneurons derived from doublecortin knockout mice

Suchergebnisse filtern